Harpoon stock: buy or sell?
February 26th, 2020
Should I buy Harpoon stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to define your own trading plan that fits your character as inversor. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Harpoon Therapeutics stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Harpoon stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for HARP stock for the last month.
Harpoon stock analysis
Harpoon rose a fine 1.73% and closed at $14.73.
Shares of Harpoon Therapeutics ended today at $14.73 and rose a fine 1.73%. On February 3rd HARP price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. HARP shows a short term strength with several rising tops and rising bottoms. In the very short term, yesterday it marked a new bottom at $14.15 that should act a support if Harpoon starts a trading flat base in the range of $14.15 - $17.24 Trading the long side, we should wait to a new breakout over $17.24 to find the next buy point. Since December when SMA50d and SMA100d crossed up, HARP price slipped $-3.97 per share (-21.23%). On December, HARP hit a new all time high, pushing higher than on December tops. Check different trading setups that use ATHs as triggers.
Harpoon eased a terrifying -3.85% this week. Early February HARP climbed a dazzling 10.81% in just one week. Late January HARP collapsed a spooky -10.01% in just one week.
Harpoon Therapeutics is in a clear downtrend, marking consecutive falling peaks and bottoms. Now is trading in between the - range. There is an opportunity to rebound and reverse this situation if price can hold above the level. Not so far away is the last price record Harpoon marked late December 2019, but since then it dropped a 31.39%. Early February HARP price bounced up over the SMA of 40 weeks that acted as support stopping new slides.
Harpoon stock price history
Harpoon stock went public on February 8th, 2019 with a price of $14.001. Since then, HARP stock surged a 5.20%, with a yearly average of 5.20%. If you had invested right after HARP's IPO a $1,000 in Harpoon stock in 2019, it would worth $52.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Harpoon stock historical price chart
HARP stock reached all-time highs on December with a price of $21.47.
Harpoon stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' HARP stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price forecast for Harpoon Therapeutics stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report on March, Harpoon Therapeutics . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw a dazzling gain of 570.90% to $4.75 million dollars. Similarly, its profit margin (compared to sales) boosted to -576.13%, that is $-27.37 million.
|2017||$0.71 M||-||$-16.83 M-2377.1%||-|
|2018||$4.75 M||570.90%||$-27.37 M-576.1%||62.60%|
Quarterly financial resultsHarpoon posted $1.06 M in revenues for 2018-Q4, a inf% up compared to previous quarter. Reported quarter income marked $-9.73 million with a profit margin of -916.29%. Profit margin remained constant a 0.00% compared to previous quarter when profit margin was nan%. When comparing sales to same quarter last year, Harpoon Therapeutics sales marked an exceptional growth and rocketed a 50.00%.
|2017-Q4||$0.71 M||-||$-4.94 M-697.7%||-|
|2018-Q4||$1.06 M||50.00%||$-9.73 M-916.3%||96.98%|
Harpoon ownershipWhen you are planning to invest in shares of a stock, it's worth to have a look its ownership structure.
Harpoon Therapeutics shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 29.23% of all shares.
In case of Harpoon Therapeutics stock, 76.52% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for HARP stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Harpoon:
|Market cap||$362.9 M|
|Total shares||24.6 M|
|Float shares||7.6 M|
|- Institutional holdings (%)||76.5%|
|- Insider holdings (%)||29.2%|
|Shares in short selling||0.0%|
|Wednesday, February 26th, 2020|
|Day range||$14.42 - $15.30|
|Average true range||$1.03|
|50d mov avg||$15.36|
|100d mov avg||$15.01|
|200d mov avg||$14.13|
Harpoon performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Harpoon Therapeutics against in the following table: